Asthma trials in South Africa
13 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in South AfricaPulmonary Rehabilitation in African Countries
- Where
- Johannesburg
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- University of Edinburgh
See details and how to joinNCT07602673 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Where
- Durban, Johannesberg, Johannesburg
- Age
- 18 years to 75 years
- People
- 252 worldwide
- Run by
- Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00 - Phase 2Taking peopleDose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Where
- Bellville, Benoni, Brackenfell, Cape Town, Durban, eMkhomazi, Somerset West
- Age
- 18 years to 75 years
- People
- 540 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Cape Town, Durban, Johannesburg, KwaDukuza, Sydenham, Welkom
- Age
- 12 years to 80 years
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- Where
- Bloemfontein, Cape Town, Centurion, George, Pretoria, Raslouw Centurion
- Age
- 6 years to 11 years
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
- Where
- Cape Town, East London, Germiston, Krugersdorp, Lenasia, Paarl
- Age
- 12 years to 17 years
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05776927 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Bellville, Cape Town, Durban, Middelburg, Thabazimbi, Vereeniging, Welkom
- Age
- 5 years to 11 years
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - Phase 3Taking peopleEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Where
- Durban, Krugersdorp, Middelburg, Panorama, Somerset West, Welkom
- Age
- 12 years to 17 years
- People
- 440 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307665 - Phase 4Not yet taking people in South AfricaPrevent Wheeze Trial
- Where
- Johannesburg
- Age
- 3 months to 24 months
- People
- 486 worldwide
- Run by
- Norwegian University of Science and Technology
See details and how to joinNCT07858773 - Phase 2Enrolling by invitationLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Benoni, Cape Town, Durban, Pretoria
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - Phase 2Taking peoplePharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
- Where
- Cape Town, George
- Age
- 6 years to 11 years
- People
- 42 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00 - Phase 2Taking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Bellville, Benoni, Bloemfontein, Cape Town, Chatsworth, Durban, George, KwaZulu, Middelburg, Pretoria, Welkom
- Age
- 18 years to 75 years
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00 - Phase 3Taking peopleAnti-Inflammatory Reliever South Africa
- Where
- Mtubatuba
- Age
- 6 years to 18 years
- People
- 1,038
- Run by
- University of KwaZulu
See details and how to joinNCT06429475